Anti-Protease Activity Deficient Secretory Leukocyte Protease Inhibitor (SLPI) Exerts Cardioprotective Effect against Myocardial Ischaemia/Reperfusion

Inhibition of proteases shows therapeutic potential. Our previous studies demonstrated the cardioprotection by the Secretory Leukocyte Protease Inhibitor (SLPI) against myocardial ischaemia/reperfusion (I/R) injury. However, it is unclear whether the cardioprotective effect of SLPI seen in our previ...

Descripción completa

Detalles Bibliográficos
Autores principales: Mongkolpathumrat, Podsawee, Kijtawornrat, Anusak, Suwan, Eukote, Unajak, Sasimanas, Panya, Aussara, Pusadee, Tonapha, Kumphune, Sarawut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138276/
https://www.ncbi.nlm.nih.gov/pubmed/35625725
http://dx.doi.org/10.3390/biomedicines10050988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138276/
https://www.ncbi.nlm.nih.gov/pubmed/35625725
http://dx.doi.org/10.3390/biomedicines10050988

Ejemplares similares